Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Syntaxin raises L16 million

Syntaxin (Abingdon, U.K.) raised L16 million ($32.8

Read the full 72 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE